A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary biological and clinical activity of BMS-986458, a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma agents in participants with relapsed/refractory non-Hodgkin Lymphoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Chłoniak nieziarniczy, który powrócił lub nie reaguje na wcześniejsze leczenie
- •Widoczne guzy dające się zmierzyć w badaniach obrazowych
- •Zgoda na stosowanie antykoncepcji podczas badania
✗ Disqualifies
- •Zły stan ogólny pacjenta uniemożliwiający uczestnictwo
- •Niezdolność do przestrzegania zasad badania
- •Wcześniejsze leczenie poprzez specjalne komórki CAR-T lub napromienianie w ciągu ostatnich 4 tygodni
- •Przeszczep szpiku kostnego lub narządu w ciągu ostatnich 3-6 miesięcy
- •Zajęcie mózgu przez nowotwór
- •Aktywna lub niekontrolowana infekcja
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (73)
Mayo Clinic in Arizona - Phoenix
Phoenix, United States
City of Hope Comprehensive Cancer Center
Duarte, United States
Local Institution - 0068
Jacksonville, United States
Moffitt Cancer Center
Tampa, United States
Dana-Farber Cancer Institute
Boston, United States
Mayo Clinic in Rochester, Minnesota
Rochester, United States
Local Institution - 0124
Omaha, United States
Local Institution - 0047
Lake Success, United States
Local Institution - 0037
New York, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Local Institution - 0045
Providence, United States
Local Institution - 0118
Antofagasta, Chile
Local Institution - 0105
Santiago, Chile
Local Institution - 0109
Santiago, Chile
Beijing Cancer hospital
Beijing, China
Local Institution - 0084
Guangzhou, China
Local Institution - 0087
Zhengzhou, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Local Institution - 0130
Nanchang, China
Local Institution - 0131
Shanghai, China
Local Institution - 0128
Hangzhou, China
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Bordeaux, France
Local Institution - 0125
Lyon, France
Hopital Claude Huriez - CHU de Lille
Lille, France
Gustave Roussy
Villejuif, France
Henri Mondor Hospital
Créteil, France
CHU SAINT ELOI - Departement Hematologie Clinique
Montpellier, France
Hôpital Saint-Louis
Paris, France
Institut Claudius Regaud
Toulouse, France
Universitätsklinikum Münster - Albert Schweitzer Campus
Münster, Germany
Universitaetsklinikum des Saarlandes
Homburg, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Helios Klinikum Berlin-Buch
Berlin, Germany
Universitaetsklinikum Essen
Essen, Germany
Local Institution - 0103
Pátrai, Greece
Local Institution - 0107
Athens, Greece
Local Institution - 0102
Athens, Greece
Local Institution - 0119
Hong Kong, Hong Kong
Local Institution - 0094
Bologna, Italy
Local Institution - 0116
Brescia, Italy
Local Institution - 0098
Milan, Italy
Local Institution - 0113
Milan, Italy
Local Institution - 0112
Pisa, Italy
Local Institution - 0111
Ravenna, Italy
Local Institution - 0115
Roma, Italy
Local Institution - 0110
Roma, Italy
Local Institution - 0097
Verona, Italy
Local Institution - 0090
Nagoya, Japan
Local Institution - 0091
Chuo-ku, Japan
University of Yamanashi Hospital
Chūō, Japan
Local Institution - 0092
Fukuoka, Japan
Maastricht UMC+
Maastricht, Netherlands
Local Institution - 0121
Amsterdam, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Local Institution - 0077
Seoul, South Korea
Local Institution - 0123
Seoul, South Korea
Local Institution - 0078
Seoul, South Korea
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Clinica Universidad de Navarra
Pamplona, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
Salamanca, Spain
Ospedale Regionale Bellinzona e Valli
Bellinzona, Switzerland
University Hospital Basel
Basel, Switzerland
Hopitaux Universitaires de Geneve (HUG)
Geneva, Switzerland
Local Institution - 0096
Ankara, Turkey (Türkiye)
Local Institution - 0101
Ankara, Turkey (Türkiye)
Local Institution - 0099
Istanbul, Turkey (Türkiye)
Local Institution - 0122
Istanbul, Turkey (Türkiye)
Local Institution - 0071
Southampton, United Kingdom
Local Institution - 0081
Manchester, United Kingdom
Local Institution - 0072
Edinburgh, United Kingdom
Trial contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
First line of the email MUST contain NCT # and Site #.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.